Cytogel Pharma
Darien
About Cytogel Pharma
Cytogel Pharma is a biopharmaceutical company developing treatments to resolve pain with substantially reduced side effects. The company develops drug candidates from the novel endomorphin family of molecules that target key pain pathways and alleviate pain. This approach is backed by scientific evidence that elucidates its mechanism of action, differentiating it from that of the existing opioids and presenting an attractive alternative treatment for people in pain.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.1M
- Funding stage: Seed
- Last round: Debt Financing (Jul 2022)
- Website: cytogelpharma.com
- Phone: 203-662-6617
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cytogel-pharma-168959 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.